Mizuho cuts Articus to neutral, cites lower-than-expected prescriptions (NASDAQ:ARQT)
IvelinRadkov/iStock via Getty Images Mizuho cut its rating of Arcutis Biotherapeutics (NASDAQ:ARQT) to neutral and slashed its price target, citing ...
IvelinRadkov/iStock via Getty Images Mizuho cut its rating of Arcutis Biotherapeutics (NASDAQ:ARQT) to neutral and slashed its price target, citing ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.